| Leptin resistance: underlying mechanisms and diagnosis |
29 |
| Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship |
28 |
| How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases |
25 |
| Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis |
23 |
| Obesity management n Prader-Willi syndrome: current perspectives |
22 |
| Obesity and nonalcoholic fatty liver disease: current perspectives |
19 |
| The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia |
15 |
| Depression in people with type 2 diabetes: current perspectives |
15 |
| Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment |
14 |
| Association between metabolic syndrome and limb muscle quantity and quality in older adults: a pilot ultrasound study |
13 |
| Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014-2015) |
13 |
| NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis |
13 |
| Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice |
12 |
| Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome |
11 |
| Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences |
11 |
| A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation |
11 |
| Self-management knowledge and practice of type 2 diabetes mellitus patients in Baghdad, Iraq: a qualitative study |
10 |
| Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia |
10 |
| lncRNA GAS5/miR-452-5p Reduces Oxidative Stress and Pyroptosis of High-Glucose-Stimulated Renal Tubular Cells |
9 |
| Prevalence and correlates of underweight and overweight/obesity among women in India: results from the National Family Health Survey 2015-2016 |
9 |
| The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders |
8 |
| Canagliflozin review - safety and efficacy profile in patients with T2DM |
8 |
| Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia |
8 |
| Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial |
8 |
| Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats |
8 |
| Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Study |
8 |
| Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-kappa B axis |
8 |
| Depressive symptoms among elderly diabetic patients in Vietnam |
8 |
| Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease |
8 |
| Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes |
7 |
| Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice |
7 |
| Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats |
7 |
| Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study |
7 |
| The role of concordant and discordant comorbidities on performance of self-care behaviors in adults with type 2 diabetes: a systematic review |
7 |
| Prevalence of diabetic comorbidities and knowledge and practices of foot care among diabetic patients: a cross-sectional study |
7 |
| The Circulating Micro-RNAs (--34a and-99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases |
7 |
| Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes |
7 |
| High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense |
6 |
| Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives |
6 |
| Medications that cause weight gain and alternatives in Canada: a narrative review |
6 |
| Decreased health-related quality of life in patients with diabetic foot problems |
6 |
| Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers |
6 |
| Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus |
6 |
| MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome |
6 |
| Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure |
6 |
| Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide |
6 |
| Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach |
6 |
| Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 317 individuals implementing Mendelian randomization |
6 |
| Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks |
6 |
| SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions |
6 |
